Skip to main content
. 2019 May 13;9:7276. doi: 10.1038/s41598-019-43532-9

Figure 4.

Figure 4

Effect of 20 days pre-treatment with QTC-4-MeOBnE (0.1 and 1 mg/kg i.g.) on amyloid cascade expression of mice submitted to ICV infusion of STZ (3 mg/kg) or saline. BACE-1 expression in (a) PFC and (b) HC; γ- secretase expression in (c) PFC and (d) HC; Protein Precursor Amyloid (APP) expression in (e) PFC and (f) HC. Results are expressed as mean ± SEM. (n = 5–6). #p < 0.05 and ###p < 0.001 when compared with the control group. *p < 0.05, **p < 0.01 and ***p < 0.001 when compared with the STZ group (two-way ANOVA followed by Newman-Keuls test).